[1]
“‘Antifungal Susceptibility Pattern of Oropharyngeal Candidiasis in Cancer Patients’”, Journal of Pharmaceutical Negative Results, pp. 458–463, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.064.